捕捉从中期到新生血管性年龄相关性黄斑变性的转变:纵向内层视网膜变薄及与神经元丢失相关的因素
研究纳入80例基线为中期年龄相关性黄斑变性(AMD)并在3个月内发展为新生血管性AMD的患眼,比较转变前后OCT内层视网膜厚度变化。结果发现新生血管出现时旁中心凹及中心凹周围内层视网膜厚度显著增加,而抗VEGF治疗开始后12个月随访时内层视网膜显著变薄,且外层限制膜改变和既往视网膜内液史与更明显的内层视网膜变薄相关。
要点
- 中期AMD转变为新生血管性AMD时,旁中心凹和中心凹周围内层视网膜厚度显著增加。
- 抗VEGF治疗开始后12个月,内层视网膜厚度较基线显著变薄。
- 外层限制膜改变和既往视网膜内液史与12个月时更明显的内层视网膜变薄相关。
核心结论
- 渗出性新生血管形成与显著的神经元丢失相关,这种丢失可在渗出消退后被检测到。
- 结构OCT检测到的形态学改变与内层神经元丢失量之间存在显著关系。
研究设计与样本
- 研究纳入80例参与者(80眼),基线为中期AMD且在3个月内发展为新生血管性AMD。
- 将新生血管性AMD转变后随访访视的OCT扫描与最后一次有中期AMD证据的访视值进行比较,以量化纵向内层视网膜改变。
- 同时定性评估反映外层视网膜或视网膜色素上皮受损的OCT特征以及渗出的存在和特征。
主要发现
- 基线时旁中心凹和中心凹周围内层视网膜厚度分别为97.6±12.9 µm和103.5±16.2 µm。
- 首次发现新生血管性AMD的访视时,旁中心凹内层视网膜厚度为99.0±12.8 µm(P=0.040),中心凹周围为107.9±19.0 µm(P=0.0007),较基线显著增加。
- 抗血管内皮生长因子治疗开始后12个月随访时,旁中心凹内层视网膜厚度为90.3±14.8 µm(P<0.0001),中心凹周围为92.0±21.3 µm(P<0.0001),较基线显著变薄。
- 12个月随访时,OCT显示外层限制膜改变和既往视网膜内液史与更明显的内层视网膜变薄相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To estimate the impact of transition from intermediate to exudative neovascular age-related macular degeneration (AMD) on the inner retina and to assess the relationship of clinical characteristics and optical coherence tomography (OCT) findings with inner retinal changes. METHODS: A total of 80 participants (80 eyes) with intermediate AMD at baseline who developed neovascular AMD within 3 months were included in the analysis. OCT scans at follow-up visits (after transition to neovascular AMD) were compared with values at the latest visit with evidence of intermediate AMD to quantify longitudinal inner retinal changes. OCT images were also reviewed for qualitative features reflecting distress of the outer retina or retinal pigment epithelium and for the presence and characteristics of exudation. RESULTS: The parafoveal and perifoveal inner retinal thicknesses were 97.6 ± 12.9 µm and 103.5 ± 16.2 µm, respectively, at baseline, and a significant increase in values was detected at the visit with first evidence of neovascular AMD (parafoveal: 99.0 ± 12.8 µm, P = 0.040; perifoveal: 107.9 ± 19.0 µm, P = 0.0007). Conversely, the inner retina was significantly thinner at the 12-month follow-up visit after initiation of the anti-vascular endothelial growth factor therapy (parafoveal: 90.3 ± 14.8 µm, P < 0.0001; perifoveal: 92.0 ± 21.3 µm, P < 0.0001). At the 12-month follow-up visit, OCT evidence of alterations of the external limiting membrane and history of previous intraretinal fluid were associated with a greater inner retinal thinning. CONCLUSIONS: The development of exudative neovascularization is associated with significant neuronal loss that may be detected once the exudation is resolved. OCT analysis demonstrated a significant relationship between morphological alterations detected using structural OCT and the amount of inner neuronal loss.
引用
- Borrelli E, Barresi C, Lari G, et al. Capturing the Transition From Intermediate to Neovascular AMD: Longitudinal Inner Retinal Thinning and Factors Associated With Neuronal Loss. Invest Ophthalmol Vis Sci. 2023. PMID: 37074695. doi:10.1167/iovs.64.4.21
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。